Risk of treatment-related deaths with vascular endothelial growth factor receptor tyrosine kinase inhibitors: a meta-analysis of 41 randomized controlled trials

Risk of treatment-related deaths with vascular endothelial growth factor receptor tyrosine kinase inhibitors: a meta-analysis of 41 randomized controlled trials

Shaodong Hong,1,* Wenfeng Fang,1,* Wenhua Liang,1,* Yue Yan,1 Ting Zhou,1 Tao Qin,1 Xuan Wu,1 Yuxiang Ma,1 Yuanyuan Zhao,1 Yunpeng Yang,1 Zhihuang Hu,1 Cong Xue,1 Xue Hou,1 Yue Chen,2 Yan Huang,1 Hongyun Zhao,1 Li Zhang1 1State Key Laboratory of Oncology in South China, Collaborative Innovation Cen...

Full description

Bibliographic Details
Main Authors: Hong SD, Fang WF, Liang WH, Yan Y, Zhou T, Qin T, Wu X, Ma YX, Zhao YY, Yang YP, Hu ZH, Xue C, Hou X, Chen Y, Huang Y, Zhao HY, Zhang L
Format: Article
Language:English
Published: Dove Medical Press 2014-10-01
Series:OncoTargets and Therapy
Online Access:http://www.dovepress.com/risk-of-treatment-related-deaths-with-vascular-endothelial-growth-fact-peer-reviewed-article-OTT

Internet

http://www.dovepress.com/risk-of-treatment-related-deaths-with-vascular-endothelial-growth-fact-peer-reviewed-article-OTT

Similar Items